Urinalysis Market

Urinalysis Market by Product (Instruments [Automated Urine Analyzers, Semi-automated Urine Analyzers, and Point-of-Care Testing Urinalysis] and Consumables [Chemical/Reagent, Kits, and Others]), Test Type (Biochemical Urinalysis, Microscopic Urinalysis, and Others), End-User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of urinary disorders, increasing prevalence of hospital-acquired infections, and growing technological advancements in urinalysis devices.

The urinalysis market was valued at USD 4,510.55 million in 2024, growing at a CAGR of 9.10% during the forecast period from 2025 to 2032 to reach USD 9,021.90 million by 2032. The rising prevalence of urinary disorders, such as urinary tract infections (UTIs) and chronic kidney diseases, and hospital acquired urinary tract infection significantly drives the demand for urinalysis, as early detection is crucial for effective treatment. Additionally, increasing awareness and health initiatives promote regular screenings, encouraging patients to seek timely diagnoses. Health organizations and campaigns educate the public about urinary health, emphasizing the importance of urinalysis in preventive care. Furthermore, the growing product development activities by key players lead to the introduction of innovative and user-friendly urinalysis devices, enhancing diagnostic accuracy and efficiency. Together, these factors create a robust market environment for urinalysis, ensuring it remains a vital component of modern healthcare during the forecast period from 2025 to 2032.

Urinalysis Market Dynamics:

According to recent data published by NHS England (2023), there were approximately 147,285 hospital admissions for individuals diagnosed with a urinary tract infection (UTI) in 2022–2023. Of these, 56% (82,392 admissions) involved individuals aged 65 and older, with the 80–84 age group recording the highest number of cases (17,280 admissions). The rising incidence of UTIs is playing a significant role in driving the urinalysis market. The increase in hospital admissions, particularly among the elderly, has heightened the demand for urinalysis solutions across hospitals, clinics, diagnostic centers, and long-term care facilities. Healthcare providers rely heavily on urine dipstick tests, urine microscopy, and urine culture analyses to confirm infections and monitor treatment progress. High recurrence rates of UTIs, especially in vulnerable populations such as nursing home residents and patients with indwelling catheters, further increase the need for frequent testing.

In addition to UTIs, the growing prevalence of kidney diseases is significantly driving the urinalysis market. According to data from the Australian Bureau of Statistics (2023), approximately 246,200 people in Australia were living with kidney disease in 2022. Conditions such as chronic kidney disease (CKD), acute kidney injury (AKI), glomerulonephritis, and diabetic nephropathy often necessitate regular monitoring of kidney function through urinalysis. Urinalysis helps detect critical abnormalities such as proteinuria (excess protein in urine), hematuria (blood in urine), and elevated creatinine levels, which are vital indicators of kidney dysfunction, thereby fueling global market growth.

Moreover, increasing product development activities and technological advancements are further bolstering the urinalysis market worldwide. For instance, in September 2022, Olive Diagnostics launched the Olive KG an AI-powered, spectroscopy-based urinalysis device. This innovative solution performs high-quality analyses of key urine parameters during each urination in a fully passive manner, eliminating the need for additional accessories.

Despite these advancements, the market faces certain challenges. Limited access to urinary tract infection testing products and services in low-income countries, coupled with poor diagnostic efficacy of some UTI testing products leading to inaccurate results, may pose slight obstacles to the growth of the urinalysis market during the forecast period (2025 to 2032).

Urinalysis Market Segment Analysis:

Urinalysis Market by Product (Instruments [Automated Urine Analyzers, Semi-automated Urine Analyzers, and Point-of-Care Testing Urinalysis] and Consumables [Chemical/Reagent, Kits, and Others]), Test Type (Biochemical Urinalysis, Microscopic Urinalysis, and Others), End-User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)  

In the product segment of the urinalysis market, automated urine analyzers under the ""instruments"" category are projected to capture a significant revenue share in 2024. These analyzers are driving market growth by enhancing efficiency, accuracy, and scalability in urinalysis testing. By reducing reliance on manual interpretation, they minimize human error and deliver more consistent and reliable results. Equipped with advanced features such as integrated flow cytometry, artificial intelligence (AI), and cloud connectivity, automated systems enable laboratories and clinics to process a higher volume of samples in less time. This capability is crucial to meet the growing demand for diagnostic testing related to urinary tract infections (UTIs), kidney diseases, and other urinary disorders.

In healthcare facilities with high patient loads, automated urine analyzers optimize resource management by reducing labor requirements and facilitating rapid diagnoses essential for emergency care and preventive health screenings. Companies like Siemens Healthineers and Sysmex Corporation have introduced automated platforms that integrate chemical and sediment analysis into a unified workflow, further enhancing operational efficiency. These systems also support remote monitoring and data integration with electronic medical records (EMRs), improving collaboration among healthcare professionals.

Moreover, automated analyzers are expanding access to high-quality urinalysis testing for smaller clinics and diagnostic laboratories, making advanced diagnostic technology more widely available. The growing emphasis on product development and technological advancements further bolsters the market. For example, in September 2022, Sysmex Corporation launched the UF-1500, a fully automated urine particle analyzer designed for urine sediment testing. The UF-1500 retains the high functionality and usability of the UF-5000 model while offering improvements tailored to user needs.

Thus, the factors mentioned above are expected to drive the growth of the automated urine analyzers segment, thereby propelling the overall urinalysis market globally.

North America is expected to dominate the overall Urinalysis market:

North America is expected to account for the largest share of the urinalysis market in 2024. The region's market growth is driven by the rising prevalence of urinary disorders, including urinary tract infections (UTIs), kidney diseases, and diabetes, which significantly increase the demand for diagnostic tests. A well-established healthcare infrastructure and widespread adoption of advanced diagnostic technologies such as automated urine analyzers and point-of-care devices further support market expansion. Moreover, growing awareness of preventive healthcare and the importance of routine screenings encourage more frequent urinalysis testing. Government initiatives and regulatory approvals for innovative products also improve market accessibility and adoption rates.

According to DelveInsight’s analysis, the United States accounted for nearly 42% of the diagnosed incident cases of complicated UTIs among the seven major markets (7MM) in 2023. Additionally, data from the National Healthcare Safety Network (NHSN) indicates that UTIs are the most common type of healthcare-associated infection in the U.S. Notably, approximately 75% of hospital-acquired UTIs are linked to urinary catheter use. This is significant given that 15–25% of hospitalized patients in the U.S. receive urinary catheters during their stay, according to the same source. The high incidence of catheter-associated UTIs underscores the urgent need for efficient urinalysis solutions in healthcare settings across the region.

Furthermore, increased product development activities in North America are propelling the urinalysis market. For instance, in October 2023, the U.S. Food and Drug Administration (FDA) cleared the Alltest Fentanyl Urine Test Cassette, the first over-the-counter test for the preliminary detection of fentanyl in urine. The test requires placing three drops of fresh urine onto a cassette containing a fentanyl test strip, with results displayed as colored lines within five minutes. Such innovations enhance early detection capabilities, further driving market growth.

Overall, the combination of rising disease prevalence, technological advancements, supportive regulatory environments, and increased awareness of routine diagnostics is expected to accelerate the growth of the urinalysis market in North America.

Urinalysis Market Key Players:

Some of the key market players operating in the urinalysis market include F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare Private Limited, Sysmex Europe SE, Abott, Carolina Liquid Chemistries, Medline Industries, LP, Mexple, Olive Diagnostics, ACON Laboratories, Thermo Fisher Scientific, Arkray, Inc., DIRUI Industrial Co., Ltd., Mindray Medical International, Eiken Chemical Co., Ltd., Greiner Bio-One, LabCorp, Sekisui Diagnostics, Teco Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and others.

Recent Developmental Activities in the Urinalysis Market:

• In August 2024, Carolina Liquid Chemistries and Medline partnered to distribute fentanyl screening tests for urinalysis.
• In July 2024, Mexple launched UroMen and UroWomen urine collection kits.

Key Takeaways From the Urinalysis Market Report Study

• Market size analysis for current urinalysis size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the urinalysis market.
• Various opportunities available for the other competitors in the urinalysis market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current urinalysis market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for urinalysis market growth in the coming future?

Target Audience Who Can be Benefited From This Urinalysis Market Report Study

• Urinalysis product providers
• Research organizations and consulting companies 
• Urinalysis-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Urinalysis 
• Various end-users who want to know more about the urinalysis market and the latest technological developments in the urinalysis market.  

Frequently Asked Questions for the Urinalysis Market:

1. What is urinalysis?

• Urinalysis is a diagnostic test that examines urine to detect and monitor various health conditions, including infections, kidney disorders, and metabolic issues. It involves assessing the physical, chemical, and microscopic properties of urine to provide insights into a person’s health status.

2. What is the market for urinalysis?

• The urinalysis market was valued at USD 4,510.55 million in 2024, growing at a CAGR of 9.10% during the forecast period from 2025 to 2032 to reach USD 9,021.90 million by 2032. 

3. What are the drivers for the global urinalysis market?

• The rising prevalence of urinary disorders, such as urinary tract infections (UTIs) chronic kidney diseases, and hospital-acquired urinary tract infections significantly drives the demand for urinalysis market. Additionally, increasing awareness and health initiatives promote regular screenings, encouraging patients to seek timely diagnoses. Health organizations and campaigns educate the public about urinary health, emphasizing the importance of urinalysis in preventive care. Furthermore, the growing product development activities by key players lead to the introduction of innovative and user-friendly urinalysis devices, enhancing diagnostic accuracy and efficiency. Together, these factors create a robust market environment for urinalysis, ensuring it remains a vital component of modern healthcare during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global urinalysis market?

• Some of the key market players operating in the urinalysis are F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare Private Limited, Sysmex Europe SE, Abott, Carolina Liquid Chemistries, Medline Industries, LP, Mexple, Olive Diagnostics, ACON Laboratories, Thermo Fisher Scientific, Arkray, Inc., DIRUI Industrial Co., Ltd., Mindray Medical International, Eiken Chemical Co., Ltd., Greiner Bio-One, LabCorp, Sekisui Diagnostics, Teco Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and others.

5. Which region has the highest share in the global urinalysis market?

• North America is expected to account for the highest proportion of the Urinalysis market in 2024, out of all regions. The rising prevalence of urinary disorders such as urinary tract infections (UTIs), kidney diseases, and diabetes significantly drives the demand for diagnostic tests. Additionally, the well-established healthcare infrastructure and widespread adoption of advanced diagnostic technologies—including automated urine analyzers and point-of-care devices—contribute to the market’s growth. Further, increasing awareness programs on preventive healthcare and routine screenings further encourage frequent urinalysis testing. Furthermore, government initiatives and regulatory approvals for innovative products enhance market accessibility.